Serum hepatic biomarkers in women with obstetric cholestasis and a concurrent SARS-CoV-2 infectionArticle Published on 2022-11-012022-11-15 Journal: The journal of obstetrics and gynaecology research [Category] SARS, 바이오마커, [키워드] age alanine aminotransferase ALT Aspartate aminotransferase association AST biliar acid Biomarker Biomarkers cholestasis COVID-19 enrolled evaluate evaluated fetal greater hospital Infection liver enzyme Obstetric obstetric cholestasis outcome Patient patients patients with SARS-CoV-2 Pregnancy pregnant women Prospective Study recruited SARS-CoV-2 SARS-COV-2 infection serum significant difference transaminases transaminases. women [DOI] 10.1111/jog.15383 PMC 바로가기
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic reviewArticle Published on 2022-10-132022-11-15 Journal: BMC Gastroenterology [Category] 진단, [키워드] article Autoimmune hepatitis benefit cellular CINAHL complications COVID-19 COVID-19 vaccination COVID-19 vaccines disease English language Evidence hepatic hepatic failure Hepatic porphyria Hepatitis hepatomegaly incidence include indicated item jaundice liver Liver disease liver enzyme Liver injury Meta Most patient Nature occur occurred offered Other pathology post-COVID-19 vaccination Protective raised rejection reported Reporting review Safety SARS-CoV-2 searched side Side effect systematic review therapy thrombosis treated vaccination vaccine. worldwide pandemic [DOI] 10.1186/s12876-022-02507-3 PMC 바로가기
COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment managementReview article Published on 2022-10-012022-10-05 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), SARS, 임상, 진단, 치료기술, 치료법, 치료제, [키워드] acute respiratory syndrome addition aggravate Asymptomatic caused Characteristics chronic liver disease cirrhosis clinical clinical manifestation Complication Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 patient Critical death disease dysfunction Epidemic extrapulmonary organs Factors hepatic function Hepatocellular carcinoma hypoxia immune increased risk infection with SARS-CoV-2 inflammatory factor storms Injury liver Liver damage Liver disease liver enzyme Liver function Liver injury liver transplant Liver transplantation management mechanism nonalcoholic fatty liver pathophysiological mechanism Patient patients prevalent public health reperfusion Respiratory disease risk SARS-CoV-2 severe disease Stress Treatment Vaccine [DOI] 10.1016/j.biopha.2022.113568 [Article Type] Review article
Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19: A double-blind placebo-controlled clinical trialArticle Published on 2022-10-012022-11-15 Journal: Phytotherapy research : PTR [Category] COVID19(2023년), SARS, 치료제, [키워드] alanine aminotransferase Anti-viral Antiviral assigned baseline clinical trial Concomitant COVID-19 cytokine release Cytokine release syndrome Dexamethasone dosage double-blind Effect effective Effectiveness Efficacy Evidence follow-up period gel Hospitalization hospitalized patient Laboratory Laboratory parameters lack liver enzyme management outbreak pandemic participant Patient patients with COVID-19 placebo group placebo-controlled clinical trial receiving Remdesivir sample sizes SARS-CoV-2 significant difference significantly silymarin. Symptom the placebo group therapeutic strategy Treatment treatment group two group viral disease were assessed [DOI] 10.1002/ptr.7537 PMC 바로가기
Evaluating the Factors Affecting COVID-19 Patients’ Mortality in Arak in 2020Article Published on 2022-09-162022-11-15 Journal: Canadian Respiratory Journal [Category] SARS, 치료제, [키워드] Acute kidney injury acute respiratory distress Admission affected age AKI Antibiotic therapy Antiviral arrhythmia blood pressure C-reactive protein cardiovascular disease cause Complication coronavirus disease Course COVID-19 creatine phosphokinase creatinine D-dimer death Diabetes Mellitus disease Disease progression elevated Evaluating expired Factor ferritin hemoglobin Hospitalization intensive care International investigated Laboratory lactate dehydrogenase liver enzyme Lung disease Lymphocytes Mortality Myocardial infarction normalized occur onset of symptom oxygen saturation pandemic patients Prevent Prothrombin time recovered patient risk factor Risk factors Sepsis syndrome Tachycardia tachypnea the disease two group underlying diseases White blood cell [DOI] 10.1155/2022/9594931 PMC 바로가기
Pharmacogenetic variants and risk of remdesivir-associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID-19COVID-19로 입원한 백만 재향 군인 프로그램 참가자의 약물 유전적 변이 및 렘데시비르 관련 간 효소 상승 위험Article Published on 2022-08-012022-09-11 Journal: Clinical and translational science [Category] COVID19(2023년), SARS, 변종, [키워드] adjusted administration age Alanine alanine aminotransferase ALT assigned association baseline black Comorbidities components conducted coronavirus disease Coronavirus disease 2019 COVID-19 CYP2C19 drug Drug administration Elevation enzyme food Hospitalized Linear regression liver enzyme liver enzymes log-transformed Million Veteran Program multifactorial multivariable model participant Participants Patient pharmacogenetic phenotype receiving Remdesivir retrospective risk Sex stratified Treatment treatment initiation variant was performed white with COVID-19 [DOI] 10.1111/cts.13313 PMC 바로가기 [Article Type] Article
A Case Report of Tolvaptan Therapy for ADPKD Patients With COVID-19. The Need for Appropriate Counselling for Temporary Drug DiscontinuationArticle Published on 2022-07-012022-11-16 Journal: In vivo (Athens, Greece) [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute kidney Acute kidney injury acute respiratory syndrome antagonist Appropriate autosomal dominant Case report cause counseling COVID-19 disease drug Elevation events indicated Infection liver enzyme male management mechanism of action occur pandemic Patient polycystic kidney disease polycystic kidney disease. Polydipsia progression receiving receptor renal report risk Safe SARS-CoV-2 SARS-COV-2 infection Side effect Side effects susceptibility symptomatic symptoms appeared temporary the patient therapy Tolvaptan treated Treatment Withdrawal [DOI] 10.21873/invivo.12924 PMC 바로가기
Changes in liver enzymes and association with prognosis in patients with COVID-19: a retrospective case-control studyCOVID-19 환자의 간 효소 변화 및 예후와의 연관성: 후향적 증례 대조 연구Article Published on 2022-07-012022-09-12 Journal: The Journal of international medical research [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] alanine aminotransferase alkaline phosphatase ALT Aspartate aminotransferase association AST blood cell count case-control study case–control study change Complete control group COVID-19 elevated enrolled examined Health healthy controls Imam investigated Iran Laboratory laboratory investigation Laboratory test liver Liver disease liver enzyme liver enzymes Liver injury liver injury. Lymphocytes Mortality Neutrophils NLR other tissues outcome measure Patient patients with COVID-19 Platelet Prognosis retrospective Reza SARS-CoV-2 single-center study survival was performed WBC White blood cell [DOI] 10.1177/03000605221110067 PMC 바로가기 [Article Type] Article
Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans아프리카계 미국인을 위한 입원 COVID-19 환자의 사망률에 대한 증상, 임상 및 바이오마커 연관성Article Published on 2022-06-172022-09-11 Journal: BMC Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, [키워드] African African American African Americans age American Analysis analyzed Asian association AST Biomarker Cancer cardiac disease Cohort collected Comorbidities Comorbidity COPD correlated COVID-19 creatinine CRP D-dimer death demographics determine diabetes Diabetes Mellitus diarrhea disease severity elevated elevated liver enzymes Ethnicity European fatigue ferritin focus Frequency Gender Glucocorticoids high mortality Hispanic hospital Hospitalized hospitalized COVID-19 patient hospitalized COVID-19 patients hypertension Immunosuppression increased risk Inflammatory biomarker laboratory data large cohort LAT Latinx liver enzyme liver enzymes Lymphocytes male Male sex mechanical ventilation Mortality mortality rates Multivariate analysis New York non-survivor Older age organ Organ failure outcome outcomes Patient patients hospitalized predictor Prevent procalcitonin progression race required SARS CoV-2 SARS CoV-2. SARS-CoV-2 Sex Shortness of breath significant variable significant variables significantly study population subsequent Symptom troponin [DOI] 10.1186/s12879-022-07520-1 PMC 바로가기 [Article Type] Article
COVID-19 Pandemic Impact on Cardiometabolic Markers in Adults in Chongqing, China: A Retrospective Cohort Study중국 충칭 성인의 심혈관 대사 표지자에 대한 COVID-19 유행성 영향: 후향적 코호트 연구Observational Study Published on 2022-06-032022-09-11 Journal: Frontiers in Public Health [Category] MERS, 바이오마커, 임상, [키워드] age Analysis analyzed ANCOVA average average age baseline blood glucose BMI cardiometabolic cardiometabolic profiles Cardiovascular health changed Chongqing Cohort concern conducted COVID-19 COVID-19 infection COVID-19 pandemic Evidence exposure time Factors fasting blood follow-up period Glucose Health health examination healthy Impact impacted influx LDL liver enzyme liver enzymes lockdown marker measure medical records Multiple linear regression multiple linear regression models non-communicable diseases obesity observational study participant profiles retrospective sedentary lifestyle sedentary lifestyle. significantly social isolation university uric acid variable Waist circumference was used weight WHR [DOI] 10.3389/fpubh.2022.859488 PMC 바로가기 [Article Type] Observational Study